Early research (Phase 1)Study completedNCT04015232
What this trial is testing
Comparative Immunogenicity Study of Multiple Doses of Proposed Pegfilgrastim Biosimilar, INTP5 of Intas Pharmaceuticals Ltd., India Against Neulasta of Amgen Inc., USA in Healthy, Adult Human Subjects.
Who this might be right for
ImmunogenicityHealthy Volunteers
Intas Pharmaceuticals, Ltd. 200